Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication. 2017

Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
Medivir AB, Box 1086, 141 22 Huddinge, Sweden. Electronic address: pedro.pinho@medivir.com.

Discovery of sofosbuvir has radically changed hepatitis C treatment and nucleoside/tide NS5B inhibitors are now viewed as one of the key components in combination therapies with other direct-acting antiviral agents. As part of our program to identify new nucleoside inhibitors of HCV replication, we now wish to report on the discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of HCV replication. Although, cytidine analogues have long been recognized to be metabolized to both cytidine and uridine triphosphates through the action of cytidine deaminase, uridine analogues are generally believed to produce exclusively uridine triphosphate. Detailed investigation of the intracellular metabolism of our newly discovered uridine prodrugs, as well as of sofosbuvir, has now revealed the formation of both uridine and cytidine triphosphates. This occurs, not only in vitro in cell lines, but also in vivo upon oral dosing to dogs.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
December 2016, ACS medicinal chemistry letters,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
May 2015, Organic & biomolecular chemistry,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
September 2012, Bioorganic & medicinal chemistry letters,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
May 2007, Bioorganic & medicinal chemistry letters,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
October 2010, Journal of medicinal chemistry,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
February 2019, Journal of medicinal chemistry,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
May 2011, Bioorganic & medicinal chemistry letters,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
May 2007, Bioorganic & medicinal chemistry letters,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
January 2013, PloS one,
Pedro Pinho, and Genadiy Kalayanov, and Hans Westerlind, and Åsa Rosenquist, and Horst Wähling, and Christian Sund, and Maria Almeida, and Susana Ayesa, and Jan Tejbrant, and Paul Targett-Adams, and Anders Eneroth, and Annelie Lindqvist
July 2017, Scientific reports,
Copied contents to your clipboard!